Comprehensive treatment of psoriatic arthritis: Managing comorbidities and extraarticular manifestations

Alexis Ogdie, Sergio Schwartzman, Lihi Eder, Ajesh B. Maharaj, Devy Zisman, Siba P Raychaudhuri, Soumya M. Reddy, Elaine Husni

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis that can lead to decreased health-related quality of life and permanent joint damage leading to functional decline. In addition to joint and skin manifestations, both psoriasis and PsA are associated with numerous comorbidities and extraarticular/cutaneous manifestations, which may influence the physician's choice of therapy. The objectives of this review are (1) to identify comorbidities in patients with PsA based on the available evidence; (2) to examine the effects of these comorbidities or extraarticular/cutaneous manifestation on the management of patients with PsA as well as the selection of therapy; and (3) to highlight research needs around comorbidities and treatment paradigms. This review is part of a treatment recommendations update initiated by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).

Original languageEnglish (US)
Pages (from-to)2315-2322
Number of pages8
JournalJournal of Rheumatology
Volume41
Issue number11
DOIs
StatePublished - Nov 1 2014

Fingerprint

Psoriatic Arthritis
Comorbidity
Skin Manifestations
Psoriasis
Joints
Therapeutics
Research
Arthritis
Quality of Life
Physicians

Keywords

  • Autoimmune ophthalmic disease
  • Cardiovascular
  • Diabetes
  • Disease obesity
  • Metabolic syndrome
  • Osteoporosis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy

Cite this

Comprehensive treatment of psoriatic arthritis : Managing comorbidities and extraarticular manifestations. / Ogdie, Alexis; Schwartzman, Sergio; Eder, Lihi; Maharaj, Ajesh B.; Zisman, Devy; Raychaudhuri, Siba P; Reddy, Soumya M.; Husni, Elaine.

In: Journal of Rheumatology, Vol. 41, No. 11, 01.11.2014, p. 2315-2322.

Research output: Contribution to journalArticle

Ogdie, A, Schwartzman, S, Eder, L, Maharaj, AB, Zisman, D, Raychaudhuri, SP, Reddy, SM & Husni, E 2014, 'Comprehensive treatment of psoriatic arthritis: Managing comorbidities and extraarticular manifestations', Journal of Rheumatology, vol. 41, no. 11, pp. 2315-2322. https://doi.org/10.3899/jrheum.140882
Ogdie, Alexis ; Schwartzman, Sergio ; Eder, Lihi ; Maharaj, Ajesh B. ; Zisman, Devy ; Raychaudhuri, Siba P ; Reddy, Soumya M. ; Husni, Elaine. / Comprehensive treatment of psoriatic arthritis : Managing comorbidities and extraarticular manifestations. In: Journal of Rheumatology. 2014 ; Vol. 41, No. 11. pp. 2315-2322.
@article{2b1d997121434d0caefdf26d4fd79d8e,
title = "Comprehensive treatment of psoriatic arthritis: Managing comorbidities and extraarticular manifestations",
abstract = "Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis that can lead to decreased health-related quality of life and permanent joint damage leading to functional decline. In addition to joint and skin manifestations, both psoriasis and PsA are associated with numerous comorbidities and extraarticular/cutaneous manifestations, which may influence the physician's choice of therapy. The objectives of this review are (1) to identify comorbidities in patients with PsA based on the available evidence; (2) to examine the effects of these comorbidities or extraarticular/cutaneous manifestation on the management of patients with PsA as well as the selection of therapy; and (3) to highlight research needs around comorbidities and treatment paradigms. This review is part of a treatment recommendations update initiated by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).",
keywords = "Autoimmune ophthalmic disease, Cardiovascular, Diabetes, Disease obesity, Metabolic syndrome, Osteoporosis",
author = "Alexis Ogdie and Sergio Schwartzman and Lihi Eder and Maharaj, {Ajesh B.} and Devy Zisman and Raychaudhuri, {Siba P} and Reddy, {Soumya M.} and Elaine Husni",
year = "2014",
month = "11",
day = "1",
doi = "10.3899/jrheum.140882",
language = "English (US)",
volume = "41",
pages = "2315--2322",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "11",

}

TY - JOUR

T1 - Comprehensive treatment of psoriatic arthritis

T2 - Managing comorbidities and extraarticular manifestations

AU - Ogdie, Alexis

AU - Schwartzman, Sergio

AU - Eder, Lihi

AU - Maharaj, Ajesh B.

AU - Zisman, Devy

AU - Raychaudhuri, Siba P

AU - Reddy, Soumya M.

AU - Husni, Elaine

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis that can lead to decreased health-related quality of life and permanent joint damage leading to functional decline. In addition to joint and skin manifestations, both psoriasis and PsA are associated with numerous comorbidities and extraarticular/cutaneous manifestations, which may influence the physician's choice of therapy. The objectives of this review are (1) to identify comorbidities in patients with PsA based on the available evidence; (2) to examine the effects of these comorbidities or extraarticular/cutaneous manifestation on the management of patients with PsA as well as the selection of therapy; and (3) to highlight research needs around comorbidities and treatment paradigms. This review is part of a treatment recommendations update initiated by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).

AB - Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis that can lead to decreased health-related quality of life and permanent joint damage leading to functional decline. In addition to joint and skin manifestations, both psoriasis and PsA are associated with numerous comorbidities and extraarticular/cutaneous manifestations, which may influence the physician's choice of therapy. The objectives of this review are (1) to identify comorbidities in patients with PsA based on the available evidence; (2) to examine the effects of these comorbidities or extraarticular/cutaneous manifestation on the management of patients with PsA as well as the selection of therapy; and (3) to highlight research needs around comorbidities and treatment paradigms. This review is part of a treatment recommendations update initiated by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).

KW - Autoimmune ophthalmic disease

KW - Cardiovascular

KW - Diabetes

KW - Disease obesity

KW - Metabolic syndrome

KW - Osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=84922413739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922413739&partnerID=8YFLogxK

U2 - 10.3899/jrheum.140882

DO - 10.3899/jrheum.140882

M3 - Article

C2 - 25362717

AN - SCOPUS:84922413739

VL - 41

SP - 2315

EP - 2322

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 11

ER -